Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Anaemia in Ovarian Carcinoma × Ferric Oxide, Saccharated × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Anemia 2 Neoplasms, Plasma Cell 1 Neoplasms 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia 1 Gynecologic Cancer 1 Anaemia in Ovarian Carcinoma 1

Interventions

iron isomaltoside 1000 1 ferryl iron 1 ferric gluconate 1 ferric derisomaltose 1 Ferric Oxide, Saccharated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06248749 2024-02-08

Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

University of Saskatchewan

Phase 3 Not yet recruiting

Anaemia in Ovarian Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡